Komori
Hitachi (6501) · FactAnnual research and development results updated

Allocating 3.3% of Revenue to R&D

First written in FY2016. . Latest entry: FY2026.

37entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2016 – FY20262016: 320162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Target Setting for the Research and Development Expense-to-Sales RatioA theme 10 companies write about · 0 as a headwind · 10 as a tailwind

The whole theme swung hardest in 2020: 1 of 7 companies on the "Worse" side.

4 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥290.3 billion, equivalent to 2.7% of revenue,」

    Annual R&D expenses were ¥290.3 billion, or 2.7% of revenue. Results in areas including IWIM, physical AI, quantum technologies, energy and the circular economy were disclosed.
  2. FY2026-H1Updated interim R&D resultsAnnual report

    「R&D expenses for the six-month consolidated period were ¥125.3 billion, equivalent to 2.6% of revenue, broken down as follows.」

    R&D expenses for the six months ended were ¥125.3 billion, or 2.6% of revenue. The breakdown was ¥48.6 billion for Connective Industries, ¥28.6 billion for Energy and ¥22.9 billion for Digital Systems & Services, among other areas.
  3. FY2025Annual research and development results updatedAnnual report

    「The Group's R&D expenses for the current consolidated fiscal year were ¥259.4 billion, equivalent to 2.7% of revenue,」

    Annual R&D expenses were ¥259.4 billion, or 2.7% of revenue. Results in areas including generative AI, quantum computers, hydrogen production and industry-academia co-creation were disclosed.
  4. FY2025-H1Updated interim R&D resultsAnnual report

    「R&D expenses for the six-month consolidated period were ¥122.5 billion, equivalent to 2.7% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 2.7% of revenue, or ¥122.5 billion.
  5. FY2024Annual research and development results updatedAnnual report

    「The Group's R&D expenses for the current consolidated fiscal year were ¥290.1 billion, equivalent to 3.0% of revenue,」

    Annual R&D expenses were ¥290.1 billion, or 3.0% of revenue. By segment, ¥91.0 billion was allocated to Connective Industries, ¥65.2 billion to Green Energy & Mobility and ¥54.1 billion to Digital Systems & Services, among other areas.
  6. FY2024-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥218.0 billion, equivalent to 3.0% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.0% of revenue, or ¥218.0 billion.
  7. FY2024-Q2Updated cumulative R&D resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥155.7 billion, equivalent to 3.1% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 3.1% of revenue, or ¥155.7 billion. ¥46.0 billion was allocated to Automotive Systems, ¥42.6 billion to Connective Industries, ¥27.8 billion to Green Energy & Mobility and ¥25.7 billion to Digital Systems & Services, among other areas.
  8. FY2024-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥73.1 billion, equivalent to 3.1% of revenue, broken down as follows.」

    R&D expenses for the three months ended were 3.1% of revenue, or ¥73.1 billion.
  9. FY2023Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥316.2 billion, equivalent to 2.9% of revenue, with the breakdown by segment and the trend in R&D expenses as follows.」

    Annual R&D expenses were 2.9% of revenue, or ¥316.2 billion. This was a slight decrease from ¥317.3 billion in the previous fiscal year.
  10. FY2023-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥232.4 billion, equivalent to 2.9% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 2.9% of revenue, or ¥232.4 billion.
  11. FY2023-Q2Updated cumulative R&D resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥155.6 billion, equivalent to 2.9% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 2.9% of revenue, or ¥155.6 billion.
  12. FY2023-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥76.3 billion, equivalent to 3.0% of revenue, broken down as follows.」

    R&D expenses for the three months ended were 3.0% of revenue, or ¥76.3 billion.
  13. FY2022Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥317.3 billion, equivalent to 3.1% of revenue, with the breakdown by segment as follows.」

    Annual R&D expenses were 3.1% of revenue, or ¥317.3 billion. ¥75.8 billion was allocated to Automotive Systems, ¥51.5 billion to IT and ¥50.5 billion to Life, among other areas.
  14. FY2022-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥228.8 billion, equivalent to 3.1% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.1% of revenue, or ¥228.8 billion. ¥55.1 billion was allocated to Automotive Systems, ¥35.6 billion to Life and ¥37.7 billion to IT.
  15. FY2022-Q2Updated cumulative R&D resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥153.5 billion, equivalent to 3.2% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 3.2% of revenue, or ¥153.5 billion. ¥38.0 billion was allocated to Automotive Systems, ¥25.6 billion to IT and ¥23.7 billion to Life, among other areas.
  16. FY2022-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥75.4 billion, equivalent to 3.2% of revenue, broken down as follows.」

    R&D expenses for the first quarter were 3.2% of revenue, or ¥75.4 billion. ¥20.2 billion was allocated to Automotive Systems.
  17. FY2021Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥293.5 billion, equivalent to 3.4% of revenue, with the breakdown by segment as follows.」

    Annual R&D expenses were 3.4% of revenue, or ¥293.5 billion.
  18. FY2021-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥202.7 billion, equivalent to 3.4% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.4% of revenue, or ¥202.7 billion.
  19. FY2021-Q2Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥129.6 billion, equivalent to 3.4% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 3.4% of revenue, or ¥129.6 billion.
  20. FY2021-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥56.3 billion, equivalent to 3.5% of revenue, broken down as follows.」

    R&D expenses for the three months ended were updated to 3.5% of revenue, or ¥56.3 billion.
  21. FY2020Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥293.7 billion, equivalent to 3.4% of revenue, with the breakdown by segment as follows.」

    Annual R&D expenses were 3.4% of revenue, or ¥293.7 billion.
  22. FY2020-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥212.4 billion, equivalent to 3.3% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.3% of revenue, or ¥212.4 billion.
  23. FY2020-Q2Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥142.2 billion, equivalent to 3.4% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 3.4% of revenue, or ¥142.2 billion.
  24. FY2020-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥68.3 billion, equivalent to 3.4% of revenue, broken down as follows.」

    R&D expenses for the first quarter were 3.4% of revenue, or ¥68.3 billion.
  25. FY2019Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥323.1 billion, equivalent to 3.4% of revenue, with the breakdown by segment as follows.」

    Annual R&D expenses were 3.4% of revenue, or ¥323.1 billion.
  26. FY2019-Q3Updated cumulative research and development results for the first nine monthsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥234.1 billion, equivalent to 3.5% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.5% of revenue, or ¥234.1 billion.
  27. FY2019-Q2Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current second quarter were ¥156.5 billion, equivalent to 3.5% of revenue, broken down as follows.」

    R&D expenses for the six months ended were 3.5% of revenue, or ¥156.5 billion.
  28. FY2019-Q1Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current first quarter were ¥75.4 billion, equivalent to 3.5% of revenue, broken down as follows.」

    R&D expenses for the three months ended were 3.5% of revenue, or ¥75.4 billion.
  29. FY2018Annual research and development results updatedAnnual report

    「R&D expenses for the fiscal year were ¥332.9 billion, equivalent to 3.6% of revenue, with the breakdown by segment as follows.」

    Annual R&D expenses were 3.6% of revenue, or ¥332.9 billion.
  30. FY2018-Q3Updated quarterly research and development resultsAnnual report

    「R&D expenses for the cumulative period of the current third quarter were ¥240.6 billion, equivalent to 3.6% of revenue, broken down as follows.」

    R&D expenses for the nine months ended were 3.6% of revenue, or ¥240.6 billion.
  31. FY2018-Q2Updated quarterly research and development resultsAnnual report

    「For the cumulative period through the second quarter, the Group's research and development expenses amounted to ¥162.2 billion, equivalent to 3.7% of revenue, with the breakdown as follows.」

    R&D expenses for the six months ended were 3.7% of revenue, or ¥162.2 billion.
  32. FY2018-Q1Updated quarterly research and development resultsAnnual report

    「For the cumulative period through the first quarter, the Group's research and development expenses amounted to ¥74.2 billion, equivalent to 3.6% of revenue, with the breakdown as follows.」

    Research and development expenses for the cumulative period through the first quarter were updated to ¥74.2 billion, or 3.6% of revenue.
  33. FY2017Annual research and development results updatedAnnual report

    「The Group's R&D expenses for the current consolidated fiscal year were ¥323.9 billion, equivalent to 3.5% of revenue, with R&D expenses by segment as follows.」

    Annual research and development expenses were updated to ¥323.9 billion, or 3.5% of revenue.
  34. FY2017-Q3Quarterly results updatedAnnual report

    「For the cumulative period through the third quarter, the Group's research and development expenses amounted to ¥234.9 billion, equivalent to 3.6% of revenue, with the breakdown as follows.」

    Research and development expenses for the cumulative period through the third quarter amounted to ¥234.9 billion, or 3.6% of revenue.
  35. FY2017-Q2Quarterly results updatedAnnual report

    「For the cumulative period through the second quarter, the Group's research and development expenses amounted to ¥158.1 billion, equivalent to 3.6% of revenue, with the breakdown as follows.」

    Research and development expenses for the cumulative period through the second quarter amounted to ¥158.1 billion, or 3.6% of revenue.
  36. FY2017-Q1Quarterly results updatedAnnual report

    「In the first quarter of the current consolidated fiscal year, the Group's R&D expenses were ¥76.4 billion, equivalent to 3.6% of revenue, broken down as follows.」

    Quarterly research and development expenses were updated to 3.6% of revenue, or ¥76.4 billion.
  37. FY2016First statedAnnual report

    「In the current fiscal year, the Group's research and development expenses amounted to ¥333.7 billion, equivalent to 3.3% of revenue. Research and development expenses by segment were as follows.」

    Research and development expenses were allocated primarily to the Social Innovation Business, as well as Information & Telecommunication, Social & Industrial, Automotive and other areas.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Hitachi's next results are scheduled for 2026-10-28. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.